Company / Income Tax per Share
Amphstar Pharmaceuticals, Inc. Income Tax per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax per Share
$0.54
FY2025
5-year range
$0.43 / $0.66
FY2021-FY2025
Trend
-13.1%
vs FY2024
Sector context
#30 of 201
Health Care
What the data says
Amphstar Pharmaceuticals, Inc.'s income tax per share of $0.54 is higher than 85% of companies in the Health Care sector (FY2025). Income Tax per Share has fluctuated over the past 10 years, ranging from $-0.07 in FY2018 to $0.66 in FY2023.
Based on SEC 10-K filings.
0.54 in FY2025 with a 5-year CAGR of +47.8%. Top quartile in the Health Care sector.
Improved from $0.66 to $0.54 over the past 2 years.
Health Care sector context is included.
Income Tax per Share over time
Growth rates
- 3-Year CAGR
- +2.9%
- 5-Year CAGR
- +47.8%
- 10-Year CAGR
- -
Sector benchmark
-60.2% below sector average
Key checks
Key Insights
- In FY2025, income tax per share decreased 13.1% year-over-year.
- Ranks #30 out of 201 companies in the Health Care sector.
- Peak income tax per share was recorded in FY2023.
- Lowest income tax per share in the period was in FY2018.
Company context
Key Data Points
- Strong profit margin: 21.8%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income Tax per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.54 | -13.1% |
| FY2024 | $0.62 | -6.7% |
| FY2023 | $0.66 | +34.5% |
| FY2022 | $0.49 | +13.3% |
| FY2021 | $0.43 | +471.5% |
| FY2020 | $0.08 | -74.2% |
| FY2019 | $0.29 | +520.1% |
| FY2018 | -$0.07 | -35.1% |
| FY2017 | -$0.05 | -148.7% |
| FY2016 | $0.11 | +162.7% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026